Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Pilot Study Evaluating Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

NCT06337084 is registered in ClinicalTrials.gov with Monopar Therapeutics as lead sponsor.

NCT NCT06337084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06337084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Pilot Study Evaluating Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Lead sponsor
Monopar Therapeutics
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 30, 2024
Completion date
December 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, colorectal cancer, gastric cancer, lung cancer, ovarian cancer, pancreatic cancer, solid tumor, adult, triple-negative breast cancer, urothelial carcinoma